Home / Surgical outcomes and neoadjuvant safety with perioperative durvalumab for muscle-invasive bladder cancer (NIAGARA)
Surgical outcomes and neoadjuvant safety with perioperative durvalumab for muscle-invasive bladder cancer (NIAGARA)
2025-03-21
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
